SLC7A11 and neoplasm: Studies have demonstrated that glucose transporter inhibitors (e.g. BAY-876) can induce disulfidptosis by obstructing glucose uptake, which leads to NADPH depletion in tumor cells with elevated SLC7A11 expression [112].